QUINN JAMES W 4

Accession 0001415889-25-016660

CIK 0000100591other

View on SEC.gov Company Profile

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 4:15 PM ET

Size

45.0 KB

Accession

0001415889-25-016660

Insider Transaction Report

Form 4

Period: 2025-06-09

ARGAN INCAGX

QUINN JAMES W

Director

Transactions

Exercise/Conversion
Common Stock
2025-06-09$40.15/sh+8,350$335,253→ 40,556 total
Exercise/Conversion
Time-Based Restricted Stock Units
2025-06-10−388→ 3,417 total
Exercise: $0.00→ Common Stock (388 underlying)
Exercise/Conversion
Common Stock
2025-06-09$35.72/sh+2,844$101,588→ 55,757 total
Exercise/Conversion
Common Stock
2025-06-10+390→ 56,557 total
Exercise/Conversion
Option to Purchase Common Stock
2025-06-09$30.44/sh−10,000$304,400→ 61,500 total
Exercise: $30.44From: 2017-01-07Exp: 2026-01-07→ Common Stock (10,000 underlying)
Exercise/Conversion
Option to Purchase Common Stock
2025-06-09$46.35/sh−10,000$463,500→ 41,500 total
Exercise: $46.35From: 2019-01-11Exp: 2028-01-11→ Common Stock (10,000 underlying)
Exercise/Conversion
Option to Purchase Common Stock
2025-06-09$35.72/sh−3,334$119,090→ 3,166 total
Exercise: $35.72From: 2023-12-16Exp: 2032-12-16→ Common Stock (3,334 underlying)
Exercise/Conversion
Option to Purchase Common Stock
2025-06-09$43.70/sh−500$21,850→ 2,666 total
Exercise: $43.70From: 2024-12-14Exp: 2033-12-14→ Common Stock (500 underlying)
Exercise/Conversion
Common Stock
2025-06-09$71.75/sh+7,053$506,053→ 15,802 total
Exercise/Conversion
Common Stock
2025-06-09$37.13/sh+4,237$157,320→ 52,913 total
Exercise/Conversion
Common Stock
2025-06-09$43.70/sh+410$17,917→ 56,167 total
Exercise/Conversion
Option to Purchase Common Stock
2025-06-09$41.19/sh−10,000$411,900→ 31,500 total
Exercise: $41.19From: 2019-12-12Exp: 2028-12-12→ Common Stock (10,000 underlying)
Exercise/Conversion
Option to Purchase Common Stock
2025-06-09$37.13/sh−5,000$185,650→ 6,500 total
Exercise: $37.13From: 2022-12-14Exp: 2031-12-14→ Common Stock (5,000 underlying)
Exercise/Conversion
Common Stock
2025-06-09$30.44/sh+8,749$266,320→ 8,749 total
Exercise/Conversion
Common Stock
2025-06-09$46.35/sh+8,096$375,250→ 23,898 total
Exercise/Conversion
Common Stock
2025-06-09$41.19/sh+8,308$342,207→ 32,206 total
Exercise/Conversion
Common Stock
2025-06-09$45.75/sh+8,120$371,490→ 48,676 total
Sale
Common Stock
2025-06-10$207.92/sh−40,000$8,316,800→ 16,557 total
Exercise/Conversion
Option to Purchase Common Stock
2025-06-09$71.75/sh−10,000$717,500→ 51,500 total
Exercise: $71.75From: 2018-01-05Exp: 2027-01-05→ Common Stock (10,000 underlying)
Exercise/Conversion
Option to Purchase Common Stock
2025-06-09$40.15/sh−10,000$401,500→ 21,500 total
Exercise: $40.15From: 2020-12-23Exp: 2029-12-23→ Common Stock (10,000 underlying)
Exercise/Conversion
Option to Purchase Common Stock
2025-06-09$45.75/sh−10,000$457,500→ 11,500 total
Exercise: $45.75From: 2021-12-14Exp: 2030-12-14→ Common Stock (10,000 underlying)

Holdings

Common Stock
(indirect: the James W. Quinn 2025 GRAT No.1)
63,014

Footnotes (11)

[F1]On June 9, 2025, the Reporting Person exercised his stock option awarded on January 7, 2016 to purchase 10,000 shares of the Issuer's common stock at a price of $30.44 per share, using the net settle method.
[F10]Pursuant to the six-month vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 12, 2024, 388 shares of Common Stock became issuable to the Reporting Person on June 10, 2025 and is adjusted for dividends
[F11]On June 10, 2025, the Reporting Person sold 40,000 shares of the Issuer's common stock on the open market at an average price of $207.92 per share.
[F2]On June 9, 2025, the Reporting Person exercised his stock option awarded on January 5, 2017 to purchase 10,000 shares of the Issuer's common stock at a price of $71.75 per share, using the net settle method.
[F3]On June 9, 2025, the Reporting Person exercised his stock option awarded on January 11, 2018 to purchase 10,000 shares of the Issuer's common stock at a price of $46.35 per share, using the net settle method.
[F4]On June 9, 2025, the Reporting Person exercised his stock option awarded on December 12, 2018 to purchase 10,000 shares of the Issuer's common stock at a price of $41.19 per share, using the net settle method.
[F5]On June 9, 2025, the Reporting Person exercised his stock option awarded on December 23, 2019 to purchase 10,000 shares of the Issuer's common stock at a price of $40.15 per share.
[F6]On June 9, 2025, the Reporting Person exercised his stock option awarded on December 14, 2020 to purchase 10,000 shares of the Issuer's common stock at a price of $45.75 per share, using the net settle method.
[F7]On June 9, 2025, the Reporting Person exercised his stock option awarded on December 14, 2021 to purchase 5,000 shares of the Issuer's common stock at a price of $37.13 per share, using the net settle method.
[F8]On June 9, 2025, the Reporting Person exercised a portion of his stock option awarded on December 16, 2022 to purchase 3,334 shares of the Issuer's common stock at a price of $35.72 per share, using the net settle method.
[F9]On June 9, 2025, the Reporting Person exercised a portion of his stock option awarded on December 14, 2023 to purchase 500 shares of the Issuer's common stock at a price of $43.70 per share, using the net settle method.

Documents

1 file

4
form4-06112025_040611.xmlPrimary

Issuer

ARGAN INC

CIK 0000100591

→

Entity typeother

Related Parties

filerCIK 0001094454

Filing Metadata

Form type: 4
Filed: Jun 10, 8:00 PM ET
Accepted: Jun 11, 4:15 PM ET
Size: 45.0 KB

View on SEC.gov